Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Doctolib is an online and mobile booking platform that helps users find doctors and make appointments.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
Universal Quantum develops utility-scale quantum computers designed to address complex computational challenges.
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
EliseAI is an AI-driven company that offers automation, streamlining workflows, and unique needs of housing and healthcare operations.
Within turns how a company actually works into structured, AI-ready context, then puts agents to work alongside people. Formerly Klarity.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
BRIUS is a healthcare company that focuses in the orthodontics and medical device industry.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Invus has invested in 117 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Biopharma. The firm invests across 30 different industry categories.
Among tracked funding rounds, Erasca received $632.5M in a Post-IPO Equity round. Invus's total known invested capital is $9.5B.
Invus's average investment size is $93.6M across its portfolio of 117 companies.
Recent Invus portfolio additions include Aclaris Therapeutics, Arcus Biosciences, Recursion Pharmaceuticals, Doctolib, Soufflé Therapeutics. These companies were founded in 2020 or later.